Early-onset Alzheimer's not always associated with memory loss

May 19, 2011 by Deborah Braconnier in Neuroscience report

(Medical Xpress) -- In a recent study published in the journal Neurology, scientists say that individuals who develop early-onset Alzheimer's in middle age are at a high risk of being misdiagnosed because many of their initial symptoms are not memory related.

Scientists, led by Dr. Albert Llado from the Hospital Clinic of Barcelona, examined the from 40 patients who had suffered from early-onset Alzheimer’s disease. Of these 40 patients, 15 had not shown any of the typical signs of memory loss. The patients had displayed language disturbances, vision problems and behavioral changes. Out of these 15 patients, 53 percent had been misdiagnosed with neurological disorders and other forms of dementia, with 47 percent still having the incorrect diagnosis at their time of death. Of the patients that did show signs of memory loss, only four percent had been misdiagnosed at the beginning.

Early-onset Alzheimer’s usually hits patients between the ages of 40 and 60, and this study stresses the importance in recognizing that is not always an initial symptom. While there is currently no cure for Alzheimer’s, there is medication and behavioral treatment designed to delay the progression of the disease. In all 40 patients in the study, there was a delay of almost three years before a diagnosis was given, even in those with issues. The scientists believe this is because most physicians do not look for dementia and Alzheimer’s in patients in this age group.

The Alzheimer’s Association reports that 5.4 million Americans currently have Alzheimer’s and of this number 200,000 of them are between the ages of 40 - 65.

More information: Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease, Neurology May 17, 2011 vol. 76 no. 20 1720-1725. doi:10.1212/WNL.0b013e31821a44dd

Abstract

Objectives: Early-onset Alzheimer disease (EOAD) diagnosis often represents a challenge because of the high frequency of atypical presentations. Our aim was to describe the clinical features, APOE genotype, and its pathologic correlations of neuropathologic confirmed EOAD.

Methods: Retrospective review of clinical data (age at onset, family history, clinical presentation, diagnostic delay, diagnosis) and APOE genotype of patients with neuropathologically confirmed EOAD (<60 years).

Results: Forty cases were selected. Mean age at onset was 54.5 years (range 46–60). The mean disease duration was 11 years with a mean diagnostic delay of 3.1 years. A total of 37.5% had a nonmemory presentation. Behavioral/executive dysfunction was the most prevalent atypical presentation. Incorrect initial clinical diagnoses were common (53%) in patients with atypical presentations, but rare when anterograde amnesia was the presenting symptom (4%). The incorrect initial clinical diagnoses were 2 behavioral variant frontotemporal lobar degeneration, 2 normal pressure hydrocephalus, 1 semantic dementia, 1 primary progressive aphasia, 1 corticobasal degeneration, 1 pseudodementia with depression, and 1 unclassifiable dementia. APOE genotype was ϵ3/ϵ3 in 59%, with no significant differences between typical and atypical presentations. APOE ϵ4 was 3.3 times more frequent in subjects with family history of AD. A total of 97.5% of the cases presented advanced neurofibrillary pathology. A total of 45% of the patients had concomitant Lewy body pathology although localized in most cases and without a significant clinical correlate.

Conclusion: One third of patients with pathologic confirmed EOAD presented with atypical symptoms. Patients with EOAD with nonamnestic presentations often receive incorrect clinical diagnoses.

© 2010 PhysOrg.com

1 /5 (1 vote)  

Rank 1 /5 (1 vote)
Relevant PhysicsForums posts
  • Poor nutrition leading to overeating?
    created6 hours ago
  • Math and dyslexia?
    createdMay 21, 2012
  • portable metabolism meter?
    createdMay 21, 2012
  • Rare medical conditions on 20/20 tonight
    createdMay 18, 2012
  • "Good" Cholesterol in Doubt
    createdMay 17, 2012
  • A couple of questions about schizophrenia
    createdMay 17, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Barrow researchers use magic for discoveries

Researchers at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center have unveiled how and why the public perceives some magic tricks in recent studies that could have real-world implications in military ...

Neuroscience created 13 hours ago | popularity not rated yet | comments 0

GPS for the brain: Researchers develop new brain map

University of Georgia researchers have developed a map of the human brain that shows great promise as a new guide to the inner workings of the body's most complex and critical organ.

Neuroscience created 20 hours ago | popularity not rated yet | comments 0 | with audio podcast

Learning and memory: The role of neo-neurons revealed

(Medical Xpress) -- Researchers at the Institut Pasteur and the CNRS have recently identified in mice the role played by neo-neurons formed in the adult brain. By using selective stimulation the researchers ...

Neuroscience created 20 hours ago | popularity 4.8 / 5 (4) | comments 0 | with audio podcast

Newly discovered protein makes sure brain development isn't 'botched'

(Medical Xpress) -- Johns Hopkins scientists have discovered a protein that appears to play an important regulatory role in deciding whether stem cells differentiate into the cells that make up the brain, as well as countless ...

Neuroscience created 23 hours ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

The heart rules the head when we make financial decisions

(Medical Xpress) -- Our 'gut feelings' influence our decisions, overriding 'rational' thought, when we are faced with financial offers that we deem to be unfair, according to a new study. Even when we are ...

Neuroscience created May 21, 2012 | popularity not rated yet | comments 0


Molecular 'on-off' switch for Parkinson's disease discovered

(Medical Xpress) -- Scientists at the Medical Research Council (MRC) Protein Phosphorylation Unit at the University of Dundee have discovered a new molecular switch that acts to protect the brain from developing Parkinson's ...

Scientists turn patients' skin cells into heart muscle cells to repair their damaged hearts

For the first time scientists have succeeded in taking skin cells from heart failure patients and reprogramming them to transform into healthy, new heart muscle cells that are capable of integrating with existing heart tissue.

Simple motions, complex tool New robot successfully performs surgical closure in a beating heart

A new robotic device may be the solution to a longstanding surgical dilemma: how to precisely manipulate tools within the delicate tissues of a beating heart, report researchers at Boston Children’s Hospital. The team’s ...

Scientists start explaining Fat Bastard's vicious cycle

Fat Bastard's revelation "I eat because I'm depressed and I'm depressed because I eat" in the Austin Powers film series may be explained by sophisticated neuroscience research being undertaken by scientists affiliated with ...

Socioeconomics may affect toddlers' exposure to flame retardants

A Duke University-led study of North Carolina toddlers suggests that exposure to potentially toxic flame-retardant chemicals may be higher in nonwhite toddlers than in white toddlers.

Hair loss pathology identified in pityriasis versicolor lesions

(HealthDay) -- Patients with pityriasis versicolor (PV) lesions may experience hair thinning and/or loss within the lesion, according to a study published online May 10 in the Journal of the American Academy of ...